Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study.
Ohnuma H, Sato Y, Hayasaka N, Matsuno T, Fujita C, Sato M, Osuga T, Hirakawa M, Miyanishi K, Sagawa T, Fujikawa K, Ohi M, Okagawa Y, Tsuji Y, Hirayama M, Ito T, Nobuoka T, Takemasa I, Kobune M, Kato J.
Ohnuma H, et al. Among authors: sato y, sato m.
Cancer Sci. 2018 Nov;109(11):3554-3563. doi: 10.1111/cas.13772. Epub 2018 Sep 25.
Cancer Sci. 2018.
PMID: 30137686
Free PMC article.
Clinical Trial.